$0.84
-0.004[-0.47%]
At close: May 6
$0.84
0[0.00%]
PreMarket: 7:46PM EDT
Vincerx Pharma
(NASDAQ:VINC)Vincerx Pharma Stock (NASDAQ:VINC), Quotes and News Summary
Vincerx Pharma Stock (NASDAQ: VINC) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 1.199M |
| Day Range | - - - |
| 52 Wk Range | 0.610 - 9.372 |
| Market Cap | $24.809M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 0 |
| Short Interest | 3.45% |
| Days to Cover | 1.44 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Vincerx Pharma (VINC) stock?
You can purchase shares of Vincerx Pharma (NASDAQ: VINC) through any online brokerage.
Who are Vincerx Pharma's (VINC) competitors?
Other companies in Vincerx Pharma’s space includes: NKGen Biotech (NASDAQ:NKGN), Serina Therapeutics (AMEX:SER), Lumos Pharma (NASDAQ:LUMO), Evaxion Biotech (NASDAQ:EVAX) and Alaunos Therapeutics (NASDAQ:TCRT).
What is the target price for Vincerx Pharma (VINC) stock?
The latest price target for Vincerx Pharma (NASDAQ: VINC) was reported by Cantor Fitzgerald on Tuesday, April 9, 2024. The analyst firm set a price target for 0.00 expecting VINC to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Vincerx Pharma (VINC)?
The stock price for Vincerx Pharma (NASDAQ: VINC) is $0.84 last updated May 6, 2024 at 7:46 PM EDT.
Does Vincerx Pharma (VINC) pay a dividend?
There are no upcoming dividends for Vincerx Pharma.
When is Vincerx Pharma (NASDAQ:VINC) reporting earnings?
Vincerx Pharma’s Q2 earnings are confirmed for Monday, August 5, 2024.
Is Vincerx Pharma (VINC) going to split?
There is no upcoming split for Vincerx Pharma.
What sector and industry does Vincerx Pharma (VINC) operate in?
Vincerx Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.